Vitality Biopharma Scientific Co-Founder to Present Recent Data at CannMed Medical Conference in Los Angeles
September 13, 2018 06:30 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development Program
June 20, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, June 20, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality Biopharma”, “Vitality”, or the “Company”) a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
March 28, 2018 08:30 ET
|
Vitality Biopharma, Inc
THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....
Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter
March 19, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, March 19, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...